Intracept Minimally-invasive Procedure for Vertebrogenic Back Pain

What this Trial Is About

Researchers are gathering real-world data on the use of the commercially approved Intracept Intraosseous Nerve Ablation System to treat patients diagnosed with vertebrogenic pain, including chronic low-back pain. The study aims to observe how patients fare following this minimally invasive procedure in a naturalistic setting without altering standard care. Participants in this observational study will receive treatment with the Intracept device as per usual medical practice and local guidelines. The study does not involve assigning treatments but monitors outcomes after patients undergo the approved nerve ablation procedure for vertebrogenic pain. During the study, participants will be followed for up to 60 months after their procedure. Researchers will assess changes in disability using the Oswestry Disability Index at baseline and throughout the follow-up period. The study focuses on collecting data on patient outcomes over time to better understand the effects of this treatment in everyday clinical use.

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain